Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
Ashley B AndersonEungjae KimAmie B ParkKangmin ZhuJie LinCraig D ShriverColonel B K PotterPublished in: The Journal of the American Academy of Orthopaedic Surgeons (2024)
MHS beneficiaries with bone sarcoma may have longer survival than SEER patients. Our findings support the role of universal access to high-quality care in improving bone sarcoma outcomes.
Keyphrases
- bone mineral density
- end stage renal disease
- soft tissue
- bone loss
- quality improvement
- chronic kidney disease
- newly diagnosed
- healthcare
- ejection fraction
- bone regeneration
- palliative care
- free survival
- prognostic factors
- postmenopausal women
- type diabetes
- metabolic syndrome
- patient reported outcomes
- affordable care act
- health insurance
- skeletal muscle